Vaxcyte PCVX
NASDAQ PCVX
$68.62 +2.26 (+3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Vaxcyte (PCVX) Current Leases (2022 - 2026)

Updated

Vaxcyte (PCVX) reported Current Leases of $10.92 million for Q3 2026.

Analysis

Vaxcyte (PCVX) Current Leases (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vaxcyte 9.91 Bn 3.83 Bn - 10.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.92 Mn
Dec 31, 2023 7.11 Mn
Dec 31, 2022 5.91 Mn
API Access

Vaxcyte Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=PCVX&period=max&api_key=YOUR_API_KEY